🦊/Investors

Bill & Melinda Gates Foundation

Foundationoperating company · company profile

Seattle · Pre-Seed–Growth · 33 people tracked

Also known as Bill & Melinda Gates Foundation Trust

Find your way into Bill & Melinda Gates Foundation

3,567 people in our graph share verified history with the Bill & Melinda Gates Foundation team — schools, employers, funds. One of them is your warm intro.

Aydin Senkutunlockedknows Sanjay Jain · together at Google (overlapped)
×2knows the team · via Google
knows the team · via IBM
×2knows the team · via Imperial Business School
×2knows the team · via Warburg Pincus
knows the team · via Roland Berger Strategy Consultants
Fox Verdict
Sign up to see your fit

Investment thesis

The Gates Foundation is a philanthropic organization with a mission to create a world where every person has the opportunity to live a healthy, productive life. For over 25 years it has worked with partners worldwide to tackle major global inequities. Its focus areas include global health innovations such as vaccine delivery and disease research, as well as agricultural development and climate-resilient food systems to reduce malnutrition and improve incomes for smallholder farmers. The foundation emphasizes measurable, results-driven outcomes.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Growth
HQ
Seattle, US
Instruments
Grants
Founded
2000
Last 12 months
1 investment
Tracked investments
29

Team · 33 people

from the firm's website & curated & public directories
Christopher J. Elias· President, Global Development

Leads efforts to strengthen systems that make health care more accessible, equitable, and effective.

14 people who came through Bill & Melinda Gates Foundation went on to found or lead other companies.

+ 2 more

What they invest in

from 27 of 29 portfolio companies

Biotech ×19Healthtech ×13Digital Health ×6Medical Devices ×6AgTech ×5Deep Tech ×4Impact & Social Good ×4SaaS ×4

HQs:United States×19India×2Argentina×1Germany×1United Kingdom×1Singapore×1

Investments · 29 tracked

founders shown can be your intro path

By year:2026 · 12024 · 42023 · 22022 · 12021 · 22020 · 12019 · 12018 · 12016 · 114 dated

CLAREMONT BIOSOLUTIONS LLCclaremontbio.com✓ verified

ClaremontBio manufactures sample preparation devices and reagents for molecular diagnostics and genomic research, including cell lysis, DNA/RNA extraction, and detection systems.

BiotechDeep TechHardwareMedical DevicesUpland, US

Gary Blackburn(CEO)

Co-investorsIn-Q-Tel

COLLABORATIVE DRUG DISCOVERY, INC.collaborativedrug.comin𝕏✓ verified

CDD provides software for collaborative research and discovery in biological and chemical sciences, serving scientists and organizations globally.

AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareSaaS

Barry Bunin(Founder & CEO)

Immunization Evidence / VoICEimmunizationevidence.org𝕏✓ verified

A searchable database of peer-reviewed evidence on the benefits of immunization, designed for child health advocates, researchers, and policymakers.

Digital HealthHealthtechImpact & Social GoodBaltimore, US

Co-investorsICONIQ

Neurosynapticneurosynaptic.comin𝕏✓ verified

Neurosynaptic Communications provides customized healthcare delivery solutions and telemedicine services designed for primary healthcare centers and underserved regions.

AI & Machine LearningDigital HealthHealthtechImpact & Social GoodSaaS

Sameer Sawarkar(Founder and CEO)inRajeev Kumar(Founder and COO)in

Co-investorsHealthQuadVenturEast

Pulapula-advisors.comin𝕏Apr 2024 · $20M✓ verified

Pula is an investment and advisory firm that operates an accelerator program in partnership with Nigeria's Sovereign Investment Authority, supporting early-stage ventures in climate resilience, agricultural technology, insurance technology, and regulatory technology across African markets.

AgTechClimate TechInsurTechNairobi, ZA

Thomas Njeru(Co-Founder and CEO)inRose Goslinga(Co-Founder and President)in

Co-investorsAccionInternational Finance CorporationMulago FoundationTLcom CapitalIFC

Raydiant Oxymetryraydiantoximetry.comin✓ verified

Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth.

Digital HealthFemTechHealthtechMedical DevicesSan Ramon, US

Neil P. Ray(Executive Officer, Director)inMichael Nagel(Chief Executive Officer)in

BoardCharles McDonald(Director)John Maroney(Director)

Co-investorsBand of AngelsFemHealth VenturesSteelSky VenturesTri-Valley VenturesAvestria VenturesRhia Ventures+3 more

SANARIA INC.sanaria.comin𝕏✓ verified

Sanaria develops malaria vaccines designed to prevent infection in at-risk populations worldwide, including pregnant women and children, with long-term goals of mass immunization campaigns and disease elimination.

BiotechHealthtechImpact & Social GoodMedical Devices

Stephen L. Hoffman(CEO)

Stellapps Technologiesstellapps.comin𝕏✓ verified

Stellapps builds the SmartMoo™ full-stack IoT platform that digitizes and optimizes milk production, procurement, and cold-chain management using sensors, big data, and machine learning.

AgTechFoodTechIoTSaaSBangalore, IN

Ranjith Mukundan(CEO)inRamakrishna Adukuri(Founder)inPraveen NaleRavishankar ShiroorinVenkatesh SeshasayeeinYawar Usmaniin

Co-investors500 GlobalBlue Ashva CapitalCelesta CapitalCelesta CapitalQualcomm VenturesBlume Ventures+2 more

Syntis Biosyntis.bioin𝕏✓ verified

Syntis Bio develops oral therapies that use the biology of the small intestine to treat conditions ranging from rare genetic disorders to common diseases.

BiotechDeep TechDigital HealthHealthtechBoston, US

Rahul Dhanda(Executive Officer, Director)inCarlo Giovanni Traverso(Director)Robert Langer(Director)

BoardTeymour Boutros-Ghali(Director)inTEYMOUR BOUTROS-GHALI(Director)inMartin Madaus(Director)

Co-investorsBold Capital PartnersCerity Partners VenturesPortal InnovationsSafar Partners

Apheaaphea.bioJul 2023

Aphea.Bio develops bioinsecticides targeting sap-sucking insects that damage crops, in partnership with Bayer to accelerate their development.

AgTechBiotech

Isabel Vercauterenin

Co-investorsAstanor VenturesEuropean Circular Bioeconomy FundInnovation IndustriesPMVV-Bio VenturesAIF+1 more

BioSurfacesbiosurfaces.usinMar 2018

BioSurfaces develops medical devices, 3D tissue engineering scaffolds, and personal care products using its proprietary Bio-Spun nanofiber technology.

BiotechMedical DevicesNew MaterialsAshland, US

Tina M Phaneuf(Executive Officer and Director of Manager)inMatthew D. Phaneuf(Executive Officer and Director of Manager)in

BoardThomas L Barrette(Director of Manager)

Cerberus Therapeuticscerberustx.cominDec 2021 · $5M

Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform.

BiotechDeep TechHealthtechBoston, US

Novalia Pishesha(Founder)inHidde Ploegh(Founder)Novalia Pishesha, PhD(Co-founder, BoD, SAB)Hidde L. Ploegh, PhD(Co-Founder, SAB)Harvey F. Lodish, PhD(Co-Founder, BoD)Xiaohong Sang(Executive Officer)

Co-investorsSherpa Healthcare Partners

E25Bioe25bio.com

BiotechCambridge, US

Bobby Herrara(Executive Officer)Bobby Brooke Herrera(Cofounder)Ann DeWitt(Director)Prashant Chouta(Executive Officer, Director)

Co-investorsBlue Ivy VenturesCastor VenturesKhosla Ventures

Ensomaensoma.comMay 2023 · $50M

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Albert Seymour(Director)

BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in

Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+7 more

Freya Biosciencesfreyabiosciences.cominNov 2024

Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.

BiotechFemTechHealthtech

Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)

Co-investorsAngelini VenturesIndaco Venture PartnersOMX VenturesSofinnova Partners

GBSgbs.comin

GBS is a German manufacturer of modular email security and management software, including its iQ.Suite, offering threat protection alongside governance, risk and compliance (GRC) capabilities.

CybersecurityEnterprise SoftwareSaaS

Co-investorsWalnut Venture Associates

Genocea Biosciencesin

Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.

BiotechCambridge, US

Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)inMichael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)

Co-investorsCycad Group LLCLux CapitalMC Healthcare VenturesAdvent Life SciencesAlexandriaAuriga Partners+1 more

Infinant Healthinfinanthealth.comin𝕏May 2026

Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.

BiotechDigital HealthFemTechHealthtechWellness & FitnessSacramento, US

J. Bruce German(Co-founder)David Mills(Co-founder)inCarlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)inMichael Johnson(Executive Officer, Director)

Co-investorsAcre Venture PartnersBow CapitalHorizons VenturesiSelect FundLongitude CapitalSpruce Capital Partners

Inventpriseinventprise.cominNov 2021

Inventprise is a clinical-stage vaccine developer using its proprietary Hydrazide-PEG-Hydrazide (Hz-PEG-Hz) linker conjugation platform to create conjugate vaccines, including a lead pediatric pneumococcal conjugate vaccine (IVT PCV-25) and candidates for Group B Streptococcus and mRNA-based vaccines.

BiotechHealthtechRedmond, US

Subhash Kapre(Manager, Co-CEO)inPradip Ghate(Chief Operating Officer)inDavid Goesling(Chief Financial Officer)inYves Leurquin(Manager, Co-CEO)in

Loowattloowatt.com

Loowatt develops a patented waterless, chemical-free flush toilet that seals waste in a lining and offers end-to-end sanitation-as-a-service, including servicing and processing of waste into biogas and fertiliser via anaerobic digestion.

Circular EconomyCleantechHardware

Virginia Gardiner(CEO + Founder)in

Co-investorsAngel AcademeOxford Investment Opportunity Network (OION)

Phase Genomicsphasegenomics.comin𝕏Mar 2024

Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity.

AI & Machine LearningBiotechHealthtechSeattle, US

Ivan Liachko(Executive Officer, Director, Promoter)inShawn Sullivan(Executive Officer, Promoter)in

Co-investorsCongruent VenturesHemi Ventures, LlcAlliance of Angels

Punackapur.comin

Puna Bio develops agricultural inputs using extremophile microorganisms from the Argentine Puna to promote sustainable farming practices.

AgTechBiotechClimate TechPuna, AR

Franco Martínez LevisinElisa Violeta BertiniinCarolina BelfioreinMaría Eugenia Faríasin

Co-investorsCapria VenturesAt One VenturesBuilders VCDalus CapitalGLOCAL LatamSOSV

Radiant Biotherapeuticsradiantbio.cominAug 2024

Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.

BiotechMedical Devices

Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)

Co-investorsFACIT (Fight Against Cancer Innovation Trust)Toronto Innovation Acceleration PartnersAmplitude Venture Capital

Swiperxswiperx.comin𝕏May 2022

SwipeRx operates a digital network for independent pharmacies and pharmacy professionals across Southeast Asia, offering community tools and a purchasing platform for buying quality medicines.

B2B MarketplacesDigital HealthHealthtech

Farouk Meralli(Founder)in

Co-investorsPatamar CapitalSpiral VenturesMDI Ventures

Synvectsynvect.comin

Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering.

AgTechBiotechClimate TechDeep TechHealthtechImpact & Social GoodSan Diego, US

Nikolay Kandul(Co-founder & CEO)inOmar Akbari(Co-founder & CSO)Pooja Y. Patel(Co-founder & CBO)inRavi Solanki(Co-founder)in

Co-investorsService Provider CapitalAntlerNuFundRedbudRedbud VC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AcrobatiqBoragenEnko ChemLyndra

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Bill & Melinda Gates Foundation made?
Bill & Melinda Gates Foundation has 29 tracked investments, including 2 dated in the last 24 months.
What stage does Bill & Melinda Gates Foundation invest at?
Bill & Melinda Gates Foundation invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
What sectors does Bill & Melinda Gates Foundation focus on?
Bill & Melinda Gates Foundation focuses on AgTech, Digital Health, EdTech, Fintech, FoodTech, Healthtech, Impact & Social Good.
Where is Bill & Melinda Gates Foundation located?
Bill & Melinda Gates Foundation is headquartered in Seattle, US.

Media · Podcasts & interviews

featuring the team

“India one of most important voices of Global South” Bill & Melinda Gates Foundation CEO Mark Suzman

ANI News · Mark Suzman

Yahoo Finance Presents: Mark Suzman, Bill & Melinda Gates Foundation CEO

Yahoo Finance · Mark Suzman

Mark Suzman, CEO, Bill & Melinda Gates Foundation - OECD DAC@60

archive-OECD Development Co-operation · Mark Suzman

Mark Suzman, CEO at The Bill & Melinda Gates Foundation — A Fireside Conversation at Harvard

HPAIR · Mark Suzman

Mark Suzman, CEO, Bill & Melinda Gates Foundation- Oxford Africa Conference 2021

Oxford Africa Conference · Mark Suzman

The UN at 75: Conversation with Mark Suzman, CEO of the Bill & Melinda Gates Foundation

Perry World House · Mark Suzman

Images

Bill & Melinda Gates Foundation photoBill & Melinda Gates Foundation photoBill & Melinda Gates Foundation photoBill & Melinda Gates Foundation photoBill & Melinda Gates Foundation photoBill & Melinda Gates Foundation photo

Similar investors

Featured in lists